Discoveries that make a difference

Almost one million Americans have a heart attack each year, and many die or are permanently disabled as a result of these events. The main cause of permanent disability is the development of heart failure. The prognosis of heart failure caused by a heart attack remains poor because there is currently no approved treatment that reverses the loss of heart muscle caused by heart attack.

The Institute of Molecular Cardiology is pioneering research to alleviate the damage caused by heart attacks and to improve the recovery of function when the heart attack causes heart failure. During the past two decades, our work has helped us understand the mechanism of heart damage and has identified many promising treatments that may become available to patients with heart failure.

Institute of Molecular Cardiology Impact

$120 million

Extramural funding

2

Active clinical trials

400+

Published journal articles

Learn more about our research

Clinical research
Our physicians investigate therapies that have the potential to alleviate the damage caused by heart attacks and improve the recovery of heart function.
Basic research
Our laboratory team pursues novel strategies to enhance the effectiveness of cell therapy for ischemic cardiomyopathy and diastolic dysfunction.
Our researchers
We collaborate with researchers across the university and around the world with the goal of improving and extending life for people with heart failure.

Contact us

Connect with the Institute of Molecular Cardiology